Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8SBC

Co-structure of Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform and brain penetrant inhibitors

8SBC の概要
エントリーDOI10.2210/pdb8sbc/pdb
分子名称Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, Phosphatidylinositol 3-kinase regulatory subunit alpha, (2M)-7-[(3R)-3-methylmorpholin-4-yl]-5-[(3S)-3-methylmorpholin-4-yl]-2-(pyridin-2-yl)-1H-imidazo[4,5-b]pyridine, ... (5 entities in total)
機能のキーワードlipid kinase, mutant, p85, nish2, brain-penetrant, mtor, transferase
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数2
化学式量合計160921.16
構造登録者
Knapp, M.S.,Elling, R.A.,Tang, J. (登録日: 2023-04-03, 公開日: 2023-07-19, 最終更新日: 2024-05-22)
主引用文献Bonazzi, S.,Gray, A.,Thomsen, N.M.,Biag, J.,Labbe-Giguere, N.,Keaney, E.P.,Malik, H.A.,Sun, Y.,Nunez, J.,Karki, R.G.,Knapp, M.,Elling, R.,Fuller, J.,Pardee, G.,Craig, L.,Capre, K.,Salas, S.,Gorde, A.,Liang, G.,Lubicka, D.,McTighe, S.M.,Goold, C.,Liu, S.,Deng, L.,Hong, J.,Fekete, A.,Stadelmann, P.,Frieauff, W.,Elhajouji, A.,Bauer, D.,Lerchner, A.,Radetich, B.,Furet, P.,Piizzi, G.,Burdette, D.,Wilson, C.J.,Peukert, S.,Hamann, L.G.,Murphy, L.O.,Curtis, D.
Identification of Brain-Penetrant ATP-Competitive mTOR Inhibitors for CNS Syndromes.
J.Med.Chem., 66:9095-9119, 2023
Cited by
PubMed Abstract: The allosteric inhibitor of the mechanistic target of rapamycin (mTOR) everolimus reduces seizures in tuberous sclerosis complex (TSC) patients through partial inhibition of mTOR functions. Due to its limited brain permeability, we sought to develop a catalytic mTOR inhibitor optimized for central nervous system (CNS) indications. We recently reported an mTOR inhibitor () that is able to block mTOR functions in the mouse brain and extend the survival of mice with neuronal-specific ablation of the 1 gene. However, showed the risk of genotoxicity . Through structure-activity relationship (SAR) optimization, we identified compounds and without genotoxicity risk. In neuronal cell-based models of mTOR hyperactivity, both corrected aberrant mTOR activity and significantly improved the survival rate of mice in the 1 gene knockout model. Unfortunately, and showed limited oral exposures in higher species and dose-limiting toxicities in cynomolgus macaque, respectively. However, they remain optimal tools to explore mTOR hyperactivity in CNS disease models.
PubMed: 37399505
DOI: 10.1021/acs.jmedchem.3c00705
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 8sbc
検証レポート(詳細版)ダウンロードをダウンロード

226707

件を2024-10-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon